Ascendis Pharma (ASND) Reports Positive Top-Line Results from Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency, Demonstrating Superiority on Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AAPL
6. ACN
7. AZN
8. ROIV
9. HOOD
10. QCOM

Go back to Ascendis Pharma (ASND) Reports Positive Top-Line Results from Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency, Demonstrating Superiority on Primary Endpoint
Asianada, Inc. (NASDAQ: ASND) Delayed: 269.42 -1.14 (0.42%)
Previous Close $270.56    52 Week High $21.79 
Open $263.41    52 Week Low $11.92 
Day High $272.47    P/E N/A 
Day Low $262.32    EPS $-0.07 
Volume 306,421